Trends of Hypercholesterolemia Change in Shenzhen, China During 1997–2018

To demonstrate the trends of hypercholesterolemia change in Shenzhen, China from 1997 to 2018. Participants were residents aged 18 to 69 years in Shenzhen, China, and were recruited using multi-stage cluster sampling. All participants were surveyed about their socio-demographics, lifestyle, occupati...

Full description

Bibliographic Details
Main Authors: Ke Peng, Weicong Cai, Xiaoying Liu, Yishu Liu, Yu Shi, Jessica Gong, Lin Lei, Ji Peng, Yuxin Xie, Honglei Zhao, Lei Si, Menglu Ouyang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.887065/full
_version_ 1818139100541091840
author Ke Peng
Ke Peng
Weicong Cai
Weicong Cai
Xiaoying Liu
Yishu Liu
Yu Shi
Jessica Gong
Lin Lei
Ji Peng
Yuxin Xie
Yuxin Xie
Honglei Zhao
Lei Si
Menglu Ouyang
Menglu Ouyang
author_facet Ke Peng
Ke Peng
Weicong Cai
Weicong Cai
Xiaoying Liu
Yishu Liu
Yu Shi
Jessica Gong
Lin Lei
Ji Peng
Yuxin Xie
Yuxin Xie
Honglei Zhao
Lei Si
Menglu Ouyang
Menglu Ouyang
author_sort Ke Peng
collection DOAJ
description To demonstrate the trends of hypercholesterolemia change in Shenzhen, China from 1997 to 2018. Participants were residents aged 18 to 69 years in Shenzhen, China, and were recruited using multi-stage cluster sampling. All participants were surveyed about their socio-demographics, lifestyle, occupation, mental health, and social support. Physical measurements and blood samples for subsequent measurements were collected according to a standardized protocol. A total of 26,621 individuals participated in the three surveys with 8,266 in 1997, 8,599 in 2009, and 9,756 in 2018. In both women and men, there was a significant downward linear trend in age-adjusted mean high-density lipoprotein-cholesterol (HDL-C) from 1997 to 2018 (women: 0.17 ± 0.06, p = 0.008 vs. men: 0.21 ± 0.04, p < 0.001). In contrast, the age-adjusted total triglycerides and total cholesterol in both sexes have demonstrated an increasing trend in the past two decades. However, no significant changes in age-adjusted low-density lipoprotein-cholesterol (LDL-C) in both men and women between 2009 and 2018 were found (women: 0.00 ± 0.02, p = 0.85 vs. men 0.02 ± 0.03, p = 0.34). The age-adjusted prevalence of hypercholesterolemia observed a rapid rise from 1997 to 2009 and appeared to be stabilized in 2018, which was similar to the trend of the prevalence of high total triglycerides in women. Changes in trends were varied by different types of lipids traits. Over the observed decades, there was a clear increasing trend of prevalence of low HDL-C (<1.04 mmol/L) in both sexes (women: 8.8% in 1997 and doubled to reach 17.5% in 2018 vs. men was 22.1% in 1997 and increased to 39.1% in 2018), particularly among younger age groups. Hence, a bespoke public health strategy aligned with the characteristics of lipids epidemic considered by sex and age groups needs to be developed and implemented.
first_indexed 2024-12-11T10:22:43Z
format Article
id doaj.art-b417a0d079b94b2eb6cc17bd47449b8d
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-12-11T10:22:43Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-b417a0d079b94b2eb6cc17bd47449b8d2022-12-22T01:11:18ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-05-011010.3389/fpubh.2022.887065887065Trends of Hypercholesterolemia Change in Shenzhen, China During 1997–2018Ke Peng0Ke Peng1Weicong Cai2Weicong Cai3Xiaoying Liu4Yishu Liu5Yu Shi6Jessica Gong7Lin Lei8Ji Peng9Yuxin Xie10Yuxin Xie11Honglei Zhao12Lei Si13Menglu Ouyang14Menglu Ouyang15National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, ChinaShenzhen Center for Chronic Disease Control, Shenzhen, ChinaShenzhen Center for Chronic Disease Control, Shenzhen, ChinaThe George Institute for Global Health, University of New South Wales, Sydney, NSW, AustraliaSchool of Medical Science, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, AustraliaThe George Institute for Global Health, University of New South Wales, Sydney, NSW, AustraliaNational Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, ChinaThe George Institute for Global Health, University of New South Wales, Sydney, NSW, AustraliaShenzhen Center for Chronic Disease Control, Shenzhen, ChinaShenzhen Center for Chronic Disease Control, Shenzhen, ChinaNational Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, ChinaSchool of Public Health, Hengyang Medical School, University of South China, Shenzhen, ChinaNational Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, ChinaThe George Institute for Global Health, University of New South Wales, Sydney, NSW, AustraliaThe George Institute for Global Health, University of New South Wales, Sydney, NSW, AustraliaThe George Institute China at Peking University Health Science Center, Beijing, ChinaTo demonstrate the trends of hypercholesterolemia change in Shenzhen, China from 1997 to 2018. Participants were residents aged 18 to 69 years in Shenzhen, China, and were recruited using multi-stage cluster sampling. All participants were surveyed about their socio-demographics, lifestyle, occupation, mental health, and social support. Physical measurements and blood samples for subsequent measurements were collected according to a standardized protocol. A total of 26,621 individuals participated in the three surveys with 8,266 in 1997, 8,599 in 2009, and 9,756 in 2018. In both women and men, there was a significant downward linear trend in age-adjusted mean high-density lipoprotein-cholesterol (HDL-C) from 1997 to 2018 (women: 0.17 ± 0.06, p = 0.008 vs. men: 0.21 ± 0.04, p < 0.001). In contrast, the age-adjusted total triglycerides and total cholesterol in both sexes have demonstrated an increasing trend in the past two decades. However, no significant changes in age-adjusted low-density lipoprotein-cholesterol (LDL-C) in both men and women between 2009 and 2018 were found (women: 0.00 ± 0.02, p = 0.85 vs. men 0.02 ± 0.03, p = 0.34). The age-adjusted prevalence of hypercholesterolemia observed a rapid rise from 1997 to 2009 and appeared to be stabilized in 2018, which was similar to the trend of the prevalence of high total triglycerides in women. Changes in trends were varied by different types of lipids traits. Over the observed decades, there was a clear increasing trend of prevalence of low HDL-C (<1.04 mmol/L) in both sexes (women: 8.8% in 1997 and doubled to reach 17.5% in 2018 vs. men was 22.1% in 1997 and increased to 39.1% in 2018), particularly among younger age groups. Hence, a bespoke public health strategy aligned with the characteristics of lipids epidemic considered by sex and age groups needs to be developed and implemented.https://www.frontiersin.org/articles/10.3389/fpubh.2022.887065/fulllipids managementhypercholesterolemiaChinacholesterolepidemiology
spellingShingle Ke Peng
Ke Peng
Weicong Cai
Weicong Cai
Xiaoying Liu
Yishu Liu
Yu Shi
Jessica Gong
Lin Lei
Ji Peng
Yuxin Xie
Yuxin Xie
Honglei Zhao
Lei Si
Menglu Ouyang
Menglu Ouyang
Trends of Hypercholesterolemia Change in Shenzhen, China During 1997–2018
Frontiers in Public Health
lipids management
hypercholesterolemia
China
cholesterol
epidemiology
title Trends of Hypercholesterolemia Change in Shenzhen, China During 1997–2018
title_full Trends of Hypercholesterolemia Change in Shenzhen, China During 1997–2018
title_fullStr Trends of Hypercholesterolemia Change in Shenzhen, China During 1997–2018
title_full_unstemmed Trends of Hypercholesterolemia Change in Shenzhen, China During 1997–2018
title_short Trends of Hypercholesterolemia Change in Shenzhen, China During 1997–2018
title_sort trends of hypercholesterolemia change in shenzhen china during 1997 2018
topic lipids management
hypercholesterolemia
China
cholesterol
epidemiology
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.887065/full
work_keys_str_mv AT kepeng trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT kepeng trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT weicongcai trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT weicongcai trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT xiaoyingliu trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT yishuliu trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT yushi trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT jessicagong trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT linlei trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT jipeng trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT yuxinxie trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT yuxinxie trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT hongleizhao trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT leisi trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT mengluouyang trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018
AT mengluouyang trendsofhypercholesterolemiachangeinshenzhenchinaduring19972018